Radboud University Medical Center
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Mindfulness Based Compassionate Living in Recurrent Depression
- Conditions
- Recurrent Depression
- Interventions
- Behavioral: Mindfulness Based Compassionate Living
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 122
- Registration Number
- NCT02059200
- Locations
- 🇳🇱
University Medical Center Nijmegen, Nijmegen, Gelderland, Netherlands
A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 52
- Registration Number
- NCT02054442
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
🇳🇱Medical Centre Haaglanden, Den Haag, Netherlands
🇳🇱Medical Centre Leeuwarden, Leeuwarden, Netherlands
Efficacy of Combining Pasireotide With Aspiration Sclerotherapy to Improve Volume Reduction of Hepatic Cysts
- Conditions
- Symptomatic Dominant Liver Cyst
- Interventions
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 34
- Registration Number
- NCT02048319
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Center; Department of Gastroenterology & Hepatology, Nijmegen, Netherlands
Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM)
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2016-01-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02045667
- Locations
- 🇳🇱
Departments of Neurology, Radboud University Nijmegen Medical Centre, the Netherlands, Nijmegen, Gelderland, Netherlands
The Immunomodulatory Effects of Phlebotomy
- Conditions
- Anemia
- Interventions
- Procedure: Phlebotomy
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02031614
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT02021123
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
🇳🇱St. Antonius hospital, Nieuwegein, Netherlands
Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
- Conditions
- Polycystic Liver DiseasePolycystic Kidney, Autosomal Dominant
- Interventions
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 34
- Registration Number
- NCT02021110
- Locations
- 🇳🇱
Radboud University Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands
🇪🇸Donostia University Hospital, San Sebastian, Spain
🇳🇱Academic Medical Centre Amsterdam, Amsterdam, Netherlands
Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer
- Conditions
- Metastatic Clear Cell Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT02002312
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Ticagrelor and Adenosine
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT01996735
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
- First Posted Date
- 2013-11-27
- Last Posted Date
- 2017-12-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT01995981
- Locations
- 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
🇬🇧Royal Marsden Hospital, London, United Kingdom